BENKOWITZ MICHAEL (PRESIDENT AND COO) sold 14.63K shares of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $7.13M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+14.63K
Price / share
$117.76
Trade value
$1.72M
% of position
Common Stock
Shares
−697.00
Price / share
$480.68
Trade value
$335.04K
% of position
Common Stock
Shares
−1.66K
Price / share
$481.86
Trade value
$798.45K
% of position
Common Stock
Shares
−873.00
Price / share
$482.72
Trade value
$421.41K
% of position
Common Stock
Shares
−697.00
Price / share
$483.80
Trade value
$337.21K
% of position
Common Stock
Shares
−1.17K
Price / share
$485.00
Trade value
$566.96K
% of position
Common Stock
Shares
−1.67K
Price / share
$486.05
Trade value
$811.22K
% of position
Common Stock
Shares
−856.00
Price / share
$487.40
Trade value
$417.22K
% of position
Common Stock
Shares
−1.19K
Price / share
$488.38
Trade value
$580.68K
% of position
Common Stock
Shares
−677.00
Price / share
$489.49
Trade value
$331.38K
% of position
Common Stock
Shares
−1.66K
Price / share
$490.11
Trade value
$813.09K
% of position
Common Stock
Shares
−1.20K
Price / share
$491.35
Trade value
$590.11K
% of position
Common Stock
Shares
−1.11K
Price / share
$492.44
Trade value
$546.61K
% of position
Common Stock
Shares
−374.00
Price / share
$493.47
Trade value
$184.56K
% of position
Common Stock
Shares
−797.00
Price / share
$494.27
Trade value
$393.94K
% of position
Net shares
+0.00
Net value
-$5.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/5/2026 | M · Option Exercise | +14.63K | $117.76 | $1.72M | New position | 0.00 | 14.63K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −697.00 | $480.68 | $335.04K | 4.8% | 14.63K | 13.93K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.66K | $481.86 | $798.45K | 11.9% | 13.93K | 12.27K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −873.00 | $482.72 | $421.41K | 7.1% | 12.27K | 11.40K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −697.00 | $483.80 | $337.21K | 6.1% | 11.40K | 10.70K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.17K | $485.00 | $566.96K | 10.9% | 10.70K | 9.53K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.67K | $486.05 | $811.22K | 17.5% | 9.53K | 7.86K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −856.00 | $487.40 | $417.22K | 10.9% | 7.86K | 7.01K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.19K | $488.38 | $580.68K | 17.0% | 7.01K | 5.82K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −677.00 | $489.49 | $331.38K | 11.6% | 5.82K | 5.14K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.66K | $490.11 | $813.09K | 32.3% | 5.14K | 3.48K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.20K | $491.35 | $590.11K | 34.5% | 3.48K | 2.28K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −1.11K | $492.44 | $546.61K | 48.7% | 2.28K | 1.17K |
| Common Stock Indirect | 1/5/2026 | S · Sale | −374.00 | $493.47 | $184.56K | 31.9% | 1.17K | 797.00 |
| Common Stock Indirect | 1/5/2026 | S · Sale | −797.00 | $494.27 | $393.94K | New position | 797.00 | 0.00 |
| Total | +0.00 | -$5.41M | ||||||
Stock Options
Common Stock
14.63K shares
Shares
−14.63K
Strike price
117.76
Held after
97.13K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Indirect | Common Stock14.63K shares | 1/5/2026 | M · Option Exercise | −14.63K | 117.76 | — | 97.13K |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.65K | Direct |
| Total | 2.65K | 2.65K direct |